Amazon received approximately $600 million in tariff refunds following a Supreme Court ruling and plans to return some funds to…
The US Senate advances a sanctions bill allowing up to 100% tariffs on countries like India and China importing large…
Despite the US imposing a 10% Section 301 duty, nearly 45% of Indian exports—including generic pharmaceuticals and smartphones—remain exempt.
US courts struck down President Trump’s broad “Liberation Day” tariffs, and new tariffs on 60 countries face legal challenges from…
Trump’s push for Gianni Infantino to lead the UN highlights political overreach, but Spain’s World Cup win shows on-field magic…
The Ministry of Commerce announced that 45% of Indian exports to the US remain exempt from new Section 301 duties,…
US President Trump doubles down on tariffs, targeting the European Union and 60 trading partners amid fines on US tech…
The latest tariff action follows investigations by the Office of the US Trade Representative (USTR) into the failure of several…
By banning imports produced with forced labour, India secured a lower 10% additional US Section 301 tariff rate compared to…
The India-US trade deal faces challenges as the US introduces new tariffs under Section 301, targeting imports linked to forced…
Indian exporters gain tariff relief as the 10% Section 122 import surcharge in the US expires, with 92% of exports…
Although India was first expected to face the higher 12.5% tariff, it was later moved to the 10% category following positive talks with the United States on labour-related…
Bernstein says Trump’s proposed tariffs on generic medicines may create near-term uncertainty, but large Indian drugmakers remain well positioned for…
US Secretary of State Marco Rubio highlighted India’s potential concerns over Trump’s proposed tariffs on imported generic medicines during talks…
Indian exporters could recover $7–8 billion in tariff refunds after the US Supreme Court struck down duties imposed under IEEPA.…
Since higher cost of operations is a major deterrent at the moment, Indian pharma companies see the likely implications in…
Track pharma stocks as Trump’s phased US tariff plan hits sentiment, though analysts say India’s cost edge may cushion generic…
US President Donald Trump announced that imported generic drugs will face 0% tariffs for two years starting August 1, followed…